Fractyl Health, Inc. Common Stock (GUTS) has a consensus analyst rating of Buy, based on 3 analysts covering the stock. Of those, 2 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for GUTS is $5.00, representing a +825.9% upside from the current price of $0.54. Price targets range from a low of $2.00 to a high of $8.00.
